Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00515229 Completed - Cystic Fibrosis Clinical Trials

Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo

Start date: October 2006
Phase: Phase 2
Study type: Interventional

Our data indicate that the CFTR-molecule functions as a transporter for sphingosine-1-phosphate and sphingosine or regulates the uptake of these sphingolipids by epithelial cells. The disturbed uptake of sphingosine and sphingosine-1-phosphate over the cell membrane results in an accumulation of ceramide in the cell membrane, which finally triggers a pro-inflammatory and pro-apoptotic status in the respiratory tract of cystic fibrosis patients. Amitriptyline reduces the cera-mide levels in the lung tissue, normalises the activity of cytokines and prevents constitutive cell death of epithelial cells observed in CFTR-deficient mice. Most important, amitriptyline prevents pulmonary infections of CFTR-deficient mice with P. aeruginosa. These effects of amitriptyline may result in an improved lung function of cystic fibrosis patients.

NCT ID: NCT00515151 Completed - Clinical trials for Bacterial Infections

Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

Start date: May 2002
Phase: Phase 4
Study type: Interventional

Health-care-acquired infections are of tremendous importance for patients, especially catheter-associated infections. More than 40% of all bloodstream infections are associated with central venous catheters (CVC; catheters which are inserted into a large vein near the heart). Of all patients that acquire such an infection 1% to 5% die as a result from it. The insertion site is the main source of contamination and infection. In general, bacteria of the skin are the cause of infection, especially in short-term CVCs (10-14 days). Therefore it is necessary to efficiently disinfect the skin for the preparation and care of CVC insertion sites. Several substances are used for disinfection. Alcohol-based disinfectants are mainly used in Central Europe, other preparations contain povidine-iodine or chlorhexidine. Alcoholic disinfectants have a rapid initial effect, chlorhexidine shows an additional remanent (longer lasting) effect. A further substance, octenidine dihydrochloride, also demonstrated a remanent effect in a pilot study with neurosurgical patients. The purpose of our study is to compare an alcohol-based disinfectant containing octenidine dihydrochloride with a pure alcoholic disinfectant regarding efficacy and tolerability in patients receiving a CVC for a minimum of 5 days.

NCT ID: NCT00515034 Completed - Pneumonia Clinical Trials

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

Start date: October 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of doripenem compared to imipenem in Ventilator-assisted pneumonia and complicated Intra-abdominal Infection. The study population will include hospitalized patients (or patients resident in a chronic health care facility) who have a diagnosis of either Ventilator associated pneumonia or complicated Intra-abdominal Infection.

NCT ID: NCT00514605 Completed - HIV Infections Clinical Trials

Testing of INSTIā„¢ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

Start date: July 2007
Phase: Phase 2/Phase 3
Study type: Interventional

Each year up to 22 million persons in the US are tested for HIV. Currently available "rapid" tests do not provide test results for at least 30 minutes from the collection of serum and plasma from the subject. Providing accurate test results in less than a minute would make it easier to make timely decisions about treatment and counselling. This study will compare results of an experimental rapid test to existing standards to determine if the test can reliably and accurately diagnose HIV in less than one minute.

NCT ID: NCT00514527 Completed - Wounds and Injuries Clinical Trials

A Study for Patients With Complicated Skin and Skin Structure Infections

SIMPLIFI
Start date: August 2007
Phase: Phase 2
Study type: Interventional

Two Phase III trials to demonstrate the efficacy and safety of oritavancin in the treatment of complicated skin and skin structure infections (cSSSI) have been completed. The pharmacokinetic profile of oritavancin in humans suggests that oritavancin has the potential to be used safely and effectively when given either as a single dose or as an infrequent dose for cSSSI. Data from animals support this theory. SIMPLIFI has been designed to evaluate the efficacy and safety of either a single dose of oritavancin or an infrequent dose of oritavancin (First dose on Day one with an option for a second dose on Day five) compared to the previously studied dosing regimen of 200mg oritavancin given once daily for 3 to 7 days.

NCT ID: NCT00513799 Completed - Clinical trials for Staphylococcus Aureus

The Natural History of Community-Associated MRSA Infections and Decolonization Strategies

StLStaRS
Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the natural history of community-associated Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate of recurrent infections in those colonized with S. aureus. In addition, this study will evaluate the efficiency of commonly prescribed decolonization measures in patients presenting with S. aureus skin and soft tissue infections.

NCT ID: NCT00513526 Completed - Infection Clinical Trials

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Start date: November 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Vaccines made from human papillomavirus may help the body build an effective immune response to kill HIV cells. PURPOSE: This phase II trial is studying the side effects and how well human papillomavirus vaccine therapy works in treating men with HIV-1 infection.

NCT ID: NCT00513461 Completed - Clinical trials for Hepatitis C Infection

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Start date: October 2007
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) works compared to a placebo in preventing liver cancer in patients with chronic hepatitis C infection. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of SAMe may keep cancer from forming in patients with advanced liver disease

NCT ID: NCT00512603 Completed - Clinical trials for Acute Coronary Syndrome

Association Between Levels of D-Dimer, Fibrinogen and PAI-1 in Elderly Patients With Infection and Occurrence of Cardio- and Cerebro-vascular Disease After Discharge

Start date: January 2007
Phase: N/A
Study type: Observational

The association between the levels of d-dimer, fibrinogen and PAI-1 in plasma of elderly patients admitted to internal medicine departments because of infection and the occurrence of cardio- and cerebro-vascular disease after discharge

NCT ID: NCT00511056 Completed - HIV Infections Clinical Trials

Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy

ARB
Start date: September 2007
Phase:
Study type: Observational

Study Hypothesis: Do certain risk behaviours impact/predict levels of HIV antiretroviral adherence? Objectives: - To assess risk behavior in HIV-positive individuals receiving highly active antiretroviral therapy.(HAART) - To assess levels of adherence in the same subjects at the same time point - To determine if there is a correlation between HAART adherence and risk behaviour